{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:51:03Z","timestamp":1779105063657,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T00:00:00Z","timestamp":1387238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["5 P20 RR020173-07"],"award-info":[{"award-number":["5 P20 RR020173-07"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.ymgmr.2013.11.002","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T17:05:49Z","timestamp":1392829549000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA"],"prefix":"10.1016","volume":"1","author":[{"given":"Yasutsugu","family":"Chinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Higa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2687-6230","authenticated-orcid":false,"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1281-2834","authenticated-orcid":false,"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Orii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hyakuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2013.11.002_bb0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-4684-7735-1_18","article-title":"The enzymic defects in Morquio and Maroteaux\u2013Lamy syndrome","volume":"68","author":"Dorfman","year":"1976","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A Registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Monta\u00f1o","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0015","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ajmg.a.32281","article-title":"Growth charts for patients affected with Morquio A disease","volume":"146","author":"Monta\u00f1o","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0020","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0025","first-page":"65","article-title":"Current and emerging treatments and surgical interventions for Morquio A syndrome: a review","volume":"2","author":"Tomatsu","year":"2012","journal-title":"Res. Rep. Endocr. Disord."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0030","series-title":"Handbook of Growth and Growth Monitoring in Health and Disease","first-page":"2091","article-title":"Impairment of body growth in mucopolysaccharidoses","author":"Tomatsu","year":"2012"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0040","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1651-2227.2009.01134.x","article-title":"Sacral dimple: incidental findings from newborn evaluation. Mucopolysaccharidosis IVA disease","volume":"98","author":"Ohashi","year":"2009","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1460-9592.2012.03904.x","article-title":"Anesthetic care and perioperative complications of children with Morquio syndrome","volume":"22","author":"Theroux","year":"2012","journal-title":"Paediatr. Anaesth."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","article-title":"Idursulfase treatment of Hunter syndrome in children younger than 6years: results from the Hunter Outcome Survey","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0065","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0070","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2004-1023","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"Harmatz","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0085","first-page":"iii","article-title":"A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type I","volume":"10","author":"Connock","year":"2006","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0090","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2165\/00003495-200767180-00005","article-title":"Treatment of lysosomal storage disorders: progress with enzyme replacement therapy","volume":"67","author":"Rohrbach","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0095","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nbt1030","article-title":"Characterizing biological products and assessing comparability following manufacturing changes","volume":"22","author":"Chirino","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0100","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003088-200645100-00002","article-title":"Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs","volume":"45","author":"Parveen","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0105","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jgm.581","article-title":"Gene therapy for lysosomal storage diseases: the lessons and promise of animal models","volume":"6","author":"Ellinwood","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/156652306776359522","article-title":"Cell and gene-based therapies for the lysosomal storage diseases","volume":"6","author":"Hodges","year":"2006","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0120","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1111\/j.1742-4658.2010.07769.x","article-title":"Adeno-associated virus gene transfer in Morquio A disease: effect of promoters and sulfatase-modifying factor 1","volume":"277","author":"Alm\u00e9ciga-D\u00edaz","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0125","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0130","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with Hurler's syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","article-title":"Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan","volume":"107","author":"Tanaka","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0140","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0145","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","article-title":"Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation","volume":"345","author":"Hoogerbrugge","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0150","first-page":"53","article-title":"The Stem Cell Transplantation Committee of the Japanese Society of Pediatric Hematology. Children with inborn errors of metabolism treated with allogeneic stem cell transplantation in Japan; a survey of 62 patients registered by 1977","volume":"107","author":"Imaizumi","year":"2003","journal-title":"J. Jpn. Pediatr. Soc."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1297\/cpe.10.113","article-title":"Bone mineral density in Japanese children and adolescents","volume":"10","author":"Nishiyama","year":"2001","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0160","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"17","author":"Tomatsu","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1302\/0301-620X.78B2.0780307","article-title":"Occipito-atlanto-axial fusion in Morquio\u2013Brailsford syndrome. A ten-year experience","volume":"78","author":"Ransford","year":"1996","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2013.04.009","article-title":"Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder","volume":"109","author":"Yasuda","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1651-2227.2010.02060.x","article-title":"Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II","volume":"100","author":"R\u00f3zdzynska","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0180","first-page":"273","article-title":"Prospective study of 11 Brazilian patients with mucopolysaccharidosis II","volume":"82","author":"Pinto","year":"2006","journal-title":"J. Pediatr. (Rio J)"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0185","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.mehy.2010.08.006","article-title":"Morquio disease: the role of cartilage canals in the pathogenesis of chondrogenic dwarfism","volume":"75","author":"Zustin","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0190","series-title":"The Metabolic Basis of Inherited Diseases","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0195","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17years","volume":"154","author":"Guffon","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701141","article-title":"Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation","volume":"21","author":"Yamada","year":"1988","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0210","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2007.04.054","article-title":"Hematopoietic cell therapy for metabolic disease","volume":"151","author":"Orchard","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2013.11.002_bb0215","series-title":"Future research needs for hematopoietic stem-cell transplantation in the pediatric population: identification of future research needs from comparative effectiveness review no. 48","author":"Belinson","year":"2012"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426913000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426913000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:50:42Z","timestamp":1762001442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426913000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":43,"alternative-id":["S2214426913000104"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2013.11.002","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2013.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}